← Open Payments lookup

JOSEPH BROWN: Open Payments

NPI 1245908292 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,036 in 58 payments from 12 companies in 2025. Trend: 2023 $790 · 2024 $1,640 · 2025 $1,036

Food & beverage: $1,036
CompanyPaymentsAmount
ABBVIE INC.16$320
AstraZeneca Pharmaceuticals LP11$200
Lilly USA, LLC9$144
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Novo Nordisk Inc5$76
Phathom Pharmaceuticals, Inc.3$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Merck Sharp & Dohme LLC2$33
Boehringer Ingelheim Pharmaceuticals, Inc.2$31
Amgen Inc.2$28

Products named: MOUNJARO, AIRSUPRA, VRAYLAR, UBRELVY, XIFAXAN, QULIPTA, Ozempic, VOQUEZNA.

Industry payments across AR — which companies pay providers there.